Aptose Biosciences Inc News - APTO

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Form 8-K - Current report

Aptose Announces Positive Clinical Safety Review Committee (CSRC) Approval to Dose Escalate in Phase 1/2 Tuscany Trial of Frontline Triple Drug Therapy with Tuspetinib Amid Complete Responses and Favorable Safety in First Cohort

TUS+VEN+AZA triplet achieves complete responses (CRs) in difficult-to-treat TP53-mutated/CK AML and...

Form 8-K - Current report

Aptose Announces Reverse Share Split

SAN DIEGO and TORONTO, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”...

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors

Form S-1 - General form for registration of securities under the Securities Act of 1933

Form 8-K - Current report

Aptose Enters into $25 Million Committed Equity Facility and Establishes New At-The-Market Facility

SAN DIEGO and TORONTO, Feb. 13, 2025 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”...

Form 8-K - Current report

Aptose’s Frontline Triple Drug Therapy with Tuspetinib Achieves Notable Responses in Newly Diagnosed AML Patients in the Phase 1/2 TUSCANY Trial

TUS+VEN+AZA triplet achieves Cycle 1 complete remission (CR) in TP53-mutated/CK AMLTUS+VEN+AZA triplet achieves...

Form 8-K - Current report

Form 424B5 - Prospectus [Rule 424(b)(5)]

Zeppo 10 hours ago

Wow.......$2.67. This thing might be ready for a "buy" after the next reverse split. There won't be much stock left.

👍️0

Zeppo 5 days ago

So....in three days post split the stock has dropped from $3.64 to $3.09.

👍️0

TrendTrade2016 1 week ago

APTO POST SPLIT POPPA

👍️0

getmoreshares 2 weeks ago

1 for 30 R/S on Feb 26th

👍️0

green maschine 2 weeks ago

R/S on Feb 26th

👍️0

Zeppo 2 weeks ago

Today's press release refers to Round 3 of dosage experiments.......this time with the combo.

👍️0

Triple nickle 2 weeks ago

For the time being it's holding on .32 ??????

👍️0

glenn1919 2 weeks ago

APTO.....................................https://stockcharts.com/h-sc/ui?s=APTO&p=W&b=5&g=0&id=p86431144783

👍️0

GalacticDruid45 3 weeks ago

REVERSE SPLIT APPROVED ( JANUARY 27, 2025 )... REVERSE SPLIT DATE ANNOUNCEMENT IMMINENT

👍️ 1

Zeppo 3 weeks ago

You'll notice that recent announcements have NOT propelled the stock upward. Reverse splits are not dilutive, but new stock offerings, to the public or as a private placement, are dilutive because they do affect the percentage of ownership for each shareholder. The product results news has been positive so far, but it will take administering the product to many more patients just to get out of Phase 1/2 and into Phase 3. I assume these stock offerings will be made post-split.

👍️0

Invest-in-America 3 weeks ago

APTO: I have to take a SONG break!! (My new Los Angeles County, California, THEME SONG!! Which should be REQUIRED LISTENING for all the STUPID County Officials who reside therein. As auditory PUNISHMENT, of sorts, for NEVER doing what has had to be accomplished there for 70+-YEARS!!! Namely, systematically REMOVING FOREVER every single TREE, BUSH, SHRUB, & BLADE OF GRASS therein!!! For at least 1.5-MILES around all housing developments throughout that stupid County!!! And then COVER that entire area permanently with GRAVEL, STONE, CONCRETE, STAINLESS STEEL, etc., FOREVER!!!)

👍️0

Invest-in-America 3 weeks ago

APTO: Looks like this has a Wall Street Police ROADBLOCK at $0.25 cents!!! (DAMN-IT!!!)

👍️0

Invest-in-America 3 weeks ago

APTO: And I hope ya take us BOTH to $2.00, by the end of this SLOOOOOOOOW day, Bro!!!!

👍️0

LowFloatLopes 3 weeks ago

In at .24

👍️0

Invest-in-America 3 weeks ago

APTO: Holy STOCK EXPLOSION, Batman!!! What-the-FLUCK was that???!!! (Fret not, Robin!!! Just continue our glorious laughin'-&-runnin' all the way to our BANK!!!)

👍️0

Invest-in-America 3 weeks ago

APTO: I grabbed some. (But, any "DD" behind this firm is [supposedly] not very encouraging; hope I'm WRONG!!)

👍️0

PinkPennies 3 weeks ago

APTO very nice news

Three patients with unmutated (wildtype) FLT3 (FLT3-WT) completed Cycle 1 of treatment with no dose-limiting toxicities (DLTs) and no dose adjustments.

Two FLT3-WT patients achieved complete remissions (CR and CRh) by the end of Cycle 1.

Notably, a patient with biallelic TP53 mutations and a complex karyotype obtained CR.

The third FLT3-WT patient experienced significant reductions in bone marrow leukemic blasts during Cycle 1 and remains on therapy in Cycle 2.

👍️0

Dantheoneman 3 weeks ago

Ticker: NXU. 600 Billion Market Merge just Approved! Moon

👍️0

TrendTrade2016 3 weeks ago

I SEE A RS HAS BEEN VOTED IN 1-10 TO 1-30

👍️0

TrendTrade2016 3 weeks ago

APTO 6 WEEKS TO DELIST...SO RS NEWS SHOULD COME SOON...

👍️0

Invest-in-America 3 weeks ago

APTO: Nice news!!!
https://finance.yahoo.com/news/aptose-frontline-triple-drug-therapy-120000446.html

👍️0

glenn1919 3 weeks ago

APTO.........................https://stockcharts.com/h-sc/ui?s=APTO&p=W&b=5&g=0&id=p86431144783

👍️0

Zeppo 1 month ago

Well......have you all seen the latest correspondence from the company? Yup........another reverse split is on the way. I was ornery and voted against it.

👍️0

glenn1919 2 months ago

APTO..........https://stockcharts.com/h-sc/ui?s=APTO&p=W&b=5&g=0&id=p86431144783

👍️0

Scotty9 2 months ago

Looks like a I’m going to take a loss on this one

👍️0

Zeppo 2 months ago

Okay, everyone. The company basically has three months to get its act together and retain its NASDAQ listing. No revenues are projected for 2025. These new collaborations are going to take time to develop. The last time the company had to scramble to retain its NASDAQ listing, what did it have to do? A reverse split. The company hasn't even been able to find its own way to Phase !!! testing with Tus....let alone Lux. So....what is it going to have to do again....unless its gets some blockbuster FDA news by March 31? Another reverse split. This day has been coming since the last reverse split was done.

👍️0

glenn1919 2 months ago

apto............................https://stockcharts.com/h-sc/ui?s=apto&p=W&b=5&g=0&id=p86431144783

👍️0

knrorrel 2 months ago

https://ih.advfn.com/stock-market/NASDAQ/aptose-biosciences-APTO/stock-news/95133778/aptose-announces-positive-decision-by-nasdaq-heari

👍️0

knrorrel 2 months ago

lol

sorry

👍️0

knrorrel 2 months ago

lol - nice Post

👍️0

tw0122 2 months ago

Nice making another round

👍️0

Invest-in-America 3 months ago

👍️0

Invest-in-America 3 months ago

APTO: No brainer here, K-N-R, in my STUPID opinion!!! (Heck, I just scalped a cheap Lotto Ticket [$1K] on @NVDI in the Post-M several minutes ago for $300 profit; 'small potatoes' for sure, but given this latest rage of JUST-RESCUED-FOR-CONTINUED-NASDAQ-LISTING late PR's, who can resist this stuff???!!!)

👍️ 1

knrorrel 3 months ago

Sounds eoic

👍️0

knrorrel 3 months ago

holy ahi_ ....coming Dollarland tomorrow ??

👍️0

Invest-in-America 3 months ago

APTO: Flip-&-scalp these NASDAQ orphans all day long!!!

👍️0

Invest-in-America 3 months ago

APTO: Back on the NASDAQ, a little more securely!!! (Another 10-bagger???)

👍️0

TheFinalCD 3 months ago

https://x.com/AlertsAndNews/status/1869852144951799886

👍️0

Zeppo 4 months ago

Well....a Phase III push for Tus is on the back burner again. First the company decides to go it alone but can't decide on a dosage. Then it wants to partner with a 2nd party.......and now a 3rd. Comments, anyone?

👍️0

tw0122 6 months ago

In some .38s looks bottomy typical hedgie beat down bio

👍️0

Monksdream 6 months ago

APTO new 52=week low

👍️0

Monksdream 6 months ago

APTO new 52 week low

👍️0

Zeppo 6 months ago

Another reverse split seems inevitable. The cash infusion, hopefully, will hasten the company to eventually reach a Phase III status on Tusp sometime during my lifetime.

👍️0

Laster 6 months ago

Bought some AH Friday. What a huge mistake.
Looks like today it will retrace back to $0.50 or lower.
Oh well.

👍️0

glenn1919 6 months ago

APTO.....................................https://stockcharts.com/h-sc/ui?s=APTO&p=W&b=5&g=0&id=p86431144783

👍️0

Imokhopeur 7 months ago

Buy

👍️0

Lilman72003 7 months ago

I’m in

👍️0

Monksdream 7 months ago

APTO new 52 week low

👍️0

Monksdream 8 months ago

APTO new 52 week low

👍️0

Zeppo 8 months ago

True to form, no revenue projections for the foreseeable future has relegated APTO to a pre-reverse split value of $.05.

👍️0

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Aptose Biosciences Inc (APTO)

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

APTO News

Form 8-K - Current report

Form 8-K - Current report

Aptose Announces Positive Clinical Safety Review Committee (CSRC) Approval to Dose Escalate in Phase 1/2 Tuscany Trial of Frontline Triple Drug Therapy with Tuspetinib Amid Complete Responses and Favorable Safety in First Cohort

Form 8-K - Current report

Aptose Announces Reverse Share Split

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors

Form S-1 - General form for registration of securities under the Securities Act of 1933

Form 8-K - Current report

Form 8-K - Current report

Aptose Enters into $25 Million Committed Equity Facility and Establishes New At-The-Market Facility

Form 8-K - Current report

Aptose’s Frontline Triple Drug Therapy with Tuspetinib Achieves Notable Responses in Newly Diagnosed AML Patients in the Phase 1/2 TUSCANY Trial

Form 8-K - Current report

Form 424B5 - Prospectus [Rule 424(b)(5)]

APTO Financials

APTO Discussion

Your Recent History

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Aptose Biosciences Inc (APTO) News

Aptose Biosciences Inc (APTO)

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

APTO News

Form 8-K - Current report

Form 8-K - Current report

Aptose Announces Positive Clinical Safety Review Committee (CSRC) Approval to Dose Escalate in Phase 1/2 Tuscany Trial of Frontline Triple Drug Therapy with Tuspetinib Amid Complete Responses and Favorable Safety in First Cohort

Form 8-K - Current report

Aptose Announces Reverse Share Split

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors

Form S-1 - General form for registration of securities under the Securities Act of 1933

Form 8-K - Current report

Form 8-K - Current report

Aptose Enters into $25 Million Committed Equity Facility and Establishes New At-The-Market Facility

Form 8-K - Current report

Aptose’s Frontline Triple Drug Therapy with Tuspetinib Achieves Notable Responses in Newly Diagnosed AML Patients in the Phase 1/2 TUSCANY Trial

Form 8-K - Current report

Form 424B5 - Prospectus [Rule 424(b)(5)]

APTO Financials

APTO Discussion

Your Recent History

Go Ad-Free